Suppr超能文献

颅内高压的管理

Management of intracranial hypertension.

作者信息

Singhi Sunit C, Tiwari Lokesh

机构信息

Pediatric Emergency Unit, Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

Indian J Pediatr. 2009 May;76(5):519-29. doi: 10.1007/s12098-009-0137-7. Epub 2009 May 24.

Abstract

Raised intracranial pressure (ICP) is a life threatening condition that is common to many neurological and non-neurological illnesses. Unless recognized and treated early it may cause secondary brain injury due to reduced cerebral perfusion pressure (CPP), and progress to brain herniation and death. Management of raised ICP includes care of airway, ventilation and oxygenation, adequate sedation and analgesia, neutral neck position, head end elevation by 20 degrees-30 degrees, and short-term hyperventilation (to achieve PCO(2) 32-35 mm Hg) and hyperosmolar therapy (mannitol or hypertonic saline) in critically raised ICP. Barbiturate coma, moderate hypothermia and surgical decompression may be helpful in refractory cases. Therapies aimed directly at keeping ICP <20 mmHg have resulted in improved survival and neurological outcome. Emerging evidence suggests that cerebral perfusion pressure targeted therapy may offer better outcome than ICP targeted therapies.

摘要

颅内压升高(ICP)是一种危及生命的状况,常见于多种神经系统和非神经系统疾病。除非早期识别并治疗,否则它可能因脑灌注压(CPP)降低而导致继发性脑损伤,并进展为脑疝和死亡。颅内压升高的管理包括气道护理、通气和氧合、充分的镇静和镇痛、颈部中立位、床头抬高20度至30度,以及在颅内压严重升高时进行短期过度通气(使PCO₂达到32 - 35 mmHg)和高渗疗法(甘露醇或高渗盐水)。巴比妥类药物昏迷、中度低温和手术减压在难治性病例中可能有帮助。直接旨在使颅内压<20 mmHg的治疗已使生存率和神经功能结局得到改善。新出现的证据表明,脑灌注压靶向治疗可能比颅内压靶向治疗提供更好的结局。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验